OPTISCAN IMAGING LIMITED (OIL)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
OIL - OPTISCAN IMAGING LIMITED
FNArena Sector :
NONE
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: N/A
Index:
FNArena Sector : NONE
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: N/A
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.17
14 Nov |
0.000 OPEN $0.17 |
0.000 HIGH $0.17 |
15,994 LOW $0.17 |
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | -0.7 |
DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 1.2 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 1.7 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -5.7 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -524.44 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -71.67 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -70.91 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | -59.70 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | -71.67 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -95.92 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -5.8 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 6 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 14.16 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 0.1 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 7.56 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 1 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 8 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | 4 M |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 0 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXTRA COVERAGE
Display All Commentary
No. Of Recommendations
Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.
OIL STOCK CHART